Consequently, IL-33 provides a selective pressure for ST2L-negative, oncosis-resistant cells, which may expand after HIF-1-dependent translocation to the proximal regions of tumour blood vessels,40 thus increasing the ratio of malignant cells (Supplementary Figure 15). The gene discussed is IL33; the disease is neoplasm.